YJR071W Antibody

What is the YJR071W antibody and what organism does it target?

The YJR071W antibody is a rabbit-derived polyclonal IgG antibody specifically designed to target the YJR071W protein (UniProt No. P47121) expressed in Saccharomyces cerevisiae (baker's yeast), specifically strain ATCC 204508/S288c . This antibody recognizes epitopes on the YJR071W protein, enabling detection and isolation of this target in various experimental applications. The antibody was generated using a recombinant YJR071W protein as the immunogen, which enhances its specificity for the target protein . As a research tool, it provides capabilities for investigating protein expression, localization, and function in yeast cellular processes.

What are the validated applications for YJR071W antibody?

The YJR071W antibody has been specifically validated for enzyme-linked immunosorbent assay (ELISA) and Western blotting (WB) applications . These validations ensure that the antibody reliably detects its target protein in these specific experimental contexts. When designing experiments, researchers should be aware that antibody performance can vary significantly between applications, and success in one application does not guarantee similar performance in another . For instance, YCharOS studies have demonstrated that antibody selectivity exhibited in Western blot should not be assumed to translate to immunofluorescence or immunoprecipitation applications without additional validation . Therefore, while the YJR071W antibody is verified for ELISA and WB, researchers seeking to use it for other applications should conduct preliminary validation experiments.

How should the YJR071W antibody be stored to maintain optimal activity?

The YJR071W antibody should be stored at -20°C or -80°C immediately upon receipt to preserve its binding capacity and specificity . Repeated freeze-thaw cycles should be avoided as they can lead to protein denaturation and loss of antibody function. The antibody is supplied in a liquid formulation containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . This storage buffer is designed to maintain antibody stability during freezing. For working solutions, small aliquots should be prepared to minimize freeze-thaw cycles. When handling the antibody, it's advisable to keep it on ice and return unused portions to cold storage promptly. Proper storage is crucial as antibody degradation can lead to reduced specificity and increased background signal in experimental applications.

How should I design proper controls when using YJR071W antibody in Western blot experiments?

When designing Western blot experiments with the YJR071W antibody, implementing rigorous controls is essential for result validation. The gold standard negative control should be a YJR071W knockout strain of Saccharomyces cerevisiae, as this genetic validation approach aligns with the International Working Group for Antibody Validation recommendations . A proper experimental design should include:

• Positive control: Wild-type S. cerevisiae (strain ATCC 204508/S288c) lysate with confirmed YJR071W expression

• Negative control: YJR071W gene knockout S. cerevisiae lysate

• Loading control: Detection of a constitutively expressed yeast protein (e.g., actin) to normalize protein loading

• Antibody specificity control: Pre-absorption of the antibody with recombinant YJR071W protein

For data interpretation, a selective antibody should show bands only in the wild-type lane and no signal in the knockout sample . If multiple bands appear in the wild-type lane, these might represent splice isoforms, multimers, or post-translationally modified forms of YJR071W . Additionally, testing the antibody across a dilution series (e.g., 1:500, 1:1000, 1:2000) can help determine optimal working concentrations for specific signal detection while minimizing background.

What are the recommended procedures for optimizing ELISA protocols with YJR071W antibody?

Optimizing ELISA protocols with YJR071W antibody requires systematic adjustment of multiple parameters to achieve maximum sensitivity and specificity. Begin with a titration matrix to determine optimal antibody concentrations:

• Coating concentration: Test serial dilutions of recombinant YJR071W protein (typically 0.1-10 μg/ml) in carbonate/bicarbonate buffer (pH 9.6)

• Blocking solution evaluation: Compare blocking efficiencies of 1-5% BSA, non-fat milk, and commercial blocking buffers to minimize non-specific binding

• Primary antibody titration: Test YJR071W antibody at dilutions ranging from 1:500 to 1:10,000

• Secondary antibody optimization: Determine appropriate HRP-conjugated anti-rabbit IgG dilution (typically 1:2,000 to 1:20,000)

• Substrate development: Optimize incubation time with TMB or other colorimetric substrates (typically 5-30 minutes)

For each parameter, analyze signal-to-noise ratios rather than absolute signal values. Include positive controls (wild-type yeast lysate) and negative controls (YJR071W knockout yeast lysate) to establish detection thresholds . Additionally, prepare a standard curve using purified recombinant YJR071W protein to enable quantification. The optimal protocol should produce a sigmoidal dose-response curve with minimal background signal and maximum dynamic range, allowing detection of physiologically relevant YJR071W concentrations.

What sample preparation methods are most effective for YJR071W detection in yeast lysates?

Effective sample preparation is crucial for optimal YJR071W detection in yeast lysates. A comprehensive methodology should include:

• Cell lysis protocol:

  • Mechanical disruption using glass beads in a bead beater (8 cycles of 30 seconds on/30 seconds off on ice)

  • Alternative: Enzymatic digestion with lyticase (100 units/ml) for 30 minutes at 30°C followed by osmotic lysis

• Lysis buffer composition:

  • Base buffer: 50 mM Tris-HCl pH 7.5, 150 mM NaCl

  • Protease inhibitors: Complete™ Protease Inhibitor Cocktail

  • Phosphatase inhibitors (if studying phosphorylation): 1 mM sodium orthovanadate, 10 mM sodium fluoride

  • Detergent: 1% Triton X-100 or 0.5% NP-40 for membrane protein solubilization

• Post-lysis processing:

  • Centrifugation at 15,000 × g for 15 minutes at 4°C to remove cellular debris

  • Protein concentration determination using Bradford or BCA assay

  • Sample denaturation in Laemmli buffer (containing 2% SDS and 5% β-mercaptoethanol) at 95°C for 5 minutes

For Western blot applications, loading 20-50 μg of total protein per lane typically provides sufficient YJR071W detection when using validated antibody dilutions . For ELISA applications, serial dilutions of lysate (1:10 to 1:1000) should be tested to establish optimal detection ranges. The specificity of detection can be verified using lysates from YJR071W knockout strains as negative controls, in accordance with the genetic validation pillar of antibody validation .

How can I validate the specificity of YJR071W antibody in my experimental system?

Validating the specificity of YJR071W antibody requires implementing multiple complementary approaches that align with the International Working Group for Antibody Validation's recommended pillars . A comprehensive validation strategy should include:

• Genetic validation:

  • Compare antibody reactivity between wild-type S. cerevisiae and YJR071W knockout strains

  • Expected outcome: Signal present only in wild-type samples and absent in knockout samples

• Orthogonal validation:

  • Correlate antibody-based detection with an antibody-independent method such as:
    a. Mass spectrometry identification of YJR071W protein
    b. RT-qPCR measurement of YJR071W mRNA levels

  • Expected outcome: Concordance between antibody signal intensity and orthogonal measurements

• Independent antibody validation:

  • Compare results using a second antibody targeting a different epitope on YJR071W

  • Expected outcome: Similar detection patterns between different antibodies

• Expression validation:

  • Test the antibody across conditions where YJR071W expression is modulated (e.g., different growth phases or nutrient conditions)

  • Expected outcome: Antibody signal corresponds to expected expression patterns

Researchers should document these validation experiments thoroughly, as the YCharOS initiative has revealed widespread issues with antibody specificity across commercial antibodies . Additionally, conducting Western blot analysis with varying antibody dilutions (1:500 to 1:5000) can help identify the optimal working concentration that maximizes specific signal while minimizing non-specific background.

What cross-reactivity concerns should I consider when using YJR071W antibody in mixed samples?

When using YJR071W antibody in mixed samples containing multiple organisms or protein sources, several cross-reactivity concerns should be carefully evaluated:

The YCharOS initiative has demonstrated that many commercial antibodies exhibit significant off-target recognition, even when manufacturers claim high specificity . For critical experiments, particularly those involving mixed cultures or complex samples, researchers should perform additional validation steps beyond the manufacturer's recommendations, potentially including mass spectrometry confirmation of presumptively identified bands.

How does the polyclonal nature of YJR071W antibody affect experimental reproducibility?

The polyclonal nature of the YJR071W antibody introduces specific considerations for experimental reproducibility that researchers must address:

• Batch-to-batch variation:

  • Polyclonal antibodies contain heterogeneous antibody populations targeting multiple epitopes

  • Different production batches may contain varying proportions of specific antibody clones

  • Solution: Always record lot numbers and prepare sufficient stock of a validated lot for critical project completion

• Epitope coverage implications:

  • Advantage: Recognition of multiple epitopes increases detection robustness against protein denaturation or modification

  • Challenge: Broader epitope recognition increases potential for cross-reactivity

  • Solution: Use more stringent washing protocols (e.g., higher salt concentration or detergent) to reduce low-affinity binding

• Quantitative analysis considerations:

  • Linear dynamic range may vary between lots due to differences in the proportion of high-affinity antibodies

  • Solution: Generate standard curves for each new lot when performing quantitative analyses

• Reproducibility enhancement strategies:

  • Implement consistent sample preparation protocols

  • Standardize incubation times and temperatures

  • Use automated washing systems when possible

  • Include calibration standards on each experimental run

The polyclonal nature also presents advantages for certain applications. Unlike monoclonal antibodies, which might lose reactivity if their specific epitope is masked or modified, polyclonal antibodies can maintain detection capability through recognition of alternative epitopes . For critical applications requiring absolute reproducibility over extended timeframes, researchers might consider epitope mapping and eventual development of monoclonal alternatives based on the most specific epitope identified.

How can YJR071W antibody be adapted for advanced protein-protein interaction studies?

Adapting YJR071W antibody for protein-protein interaction studies requires strategic modifications to standard immunoprecipitation protocols:

• Native complex preservation:

  • Use gentle lysis conditions (0.1-0.5% NP-40 or digitonin instead of stronger detergents)

  • Maintain physiological salt concentrations (120-150 mM NaCl)

  • Supplement buffers with stabilizing agents (5-10% glycerol, 1 mM DTT)

  • Perform all steps at 4°C to minimize complex dissociation

• Antibody coupling strategies:

  • Direct coupling to activated agarose or magnetic beads using NHS-ester chemistry

  • Optimization of antibody density (typically 1-5 μg antibody per μl of bead volume)

  • Chemical crosslinking of antibody to Protein A/G beads using BS3 or DMP to prevent antibody leaching into elution fractions

• Advanced interaction detection methods:

  • Sequential immunoprecipitation (first with YJR071W antibody, then with antibody against suspected interaction partner)

  • Proximity ligation assay (PLA) for in situ detection of protein-protein interactions

  • FRET-based approaches when using fluorescently tagged interaction partners

• Mass spectrometry validation:

  • Perform IP-MS using YJR071W antibody to identify the complete interactome

  • Analyze both standard and crosslinked samples to detect transient interactions

  • Use SILAC or TMT labeling for quantitative comparison between experimental conditions

For critical interaction studies, validation is essential using orthogonal methods such as yeast two-hybrid assays or recombinant protein binding studies . Research publications may require validation of antibody specificity as addressed by YCharOS guidelines, ensuring reproducibility of interaction data . Additionally, computational approaches can help predict potential interaction partners based on protein structure and function, guiding experimental design.

What strategies can resolve inconsistent results when using YJR071W antibody across different experimental platforms?

Resolving inconsistent results when using YJR071W antibody across different platforms requires systematic troubleshooting and protocol optimization:

• Antibody characterization assessment:

  • Determine binding characteristics (affinity, epitope accessibility) under different sample preparation conditions

  • Perform titration series across platforms to identify optimal working concentrations

  • Evaluate buffer compatibility effects on antibody performance

• Platform-specific optimization matrices:

  Platform	Critical Parameters	Optimization Strategy
  Western Blot	Transfer efficiency, blocking agent	Test PVDF vs. nitrocellulose; optimize blocking time and composition
  ELISA	Surface binding, washing stringency	Compare direct vs. sandwich format; adjust washing buffer composition
  Flow Cytometry	Fixation method, permeabilization	Test paraformaldehyde vs. methanol fixation; optimize permeabilization time
  Immunofluorescence	Fixation artifacts, antigen retrieval	Compare different fixatives; test epitope unmasking techniques

• Sample preparation harmonization:

  • Standardize lysis conditions across applications

  • Unify protein denaturation methods when possible

  • Implement consistent post-translational modification preservation strategies

• Cross-validation approach:

  • Employ genetic controls (knockout samples) across all platforms

  • Use orthogonal detection methods to confirm results

  • Implement spike-in standards for quantitative normalization

Research from YCharOS has demonstrated that antibody performance rarely translates perfectly between applications . Even when an antibody shows excellent selectivity in Western blot, this does not guarantee similar performance in immunofluorescence or other applications . Creating platform-specific validation protocols and regularly reassessing antibody performance can help ensure consistency in long-term research projects.

How can I apply computational approaches to enhance YJR071W antibody-based experimental design?

Computational approaches can significantly enhance YJR071W antibody-based experimental design through several sophisticated strategies:

• Epitope prediction and analysis:

  • Use algorithms like BepiPred or DiscoTope to predict linear and conformational epitopes on YJR071W

  • Model potential cross-reactive epitopes in related proteins

  • Simulate epitope accessibility under different experimental conditions (native vs. denatured)

  • Application: Design experiments that maximize epitope exposure based on predicted structural characteristics

• Structure-guided experimental design:

  • Generate 3D structural models of YJR071W using AlphaFold2 or similar tools

  • Identify domains likely to be accessible in various experimental contexts

  • Predict post-translational modification sites that might affect antibody binding

  • Application: Optimize sample preparation methods to preserve critical structural features

• Data integration and interpretation:

  • Utilize machine learning algorithms to identify patterns in antibody performance across experimental conditions

  • Implement Bayesian statistical approaches to quantify confidence in antibody-based measurements

  • Develop computational pipelines for automated background subtraction and signal normalization

  • Application: Create standardized analysis workflows that account for batch effects and technical variations

• Advanced validation strategies:

  • Employ sequence alignment tools to identify potential cross-reactive proteins across species

  • Use molecular dynamics simulations to predict antibody-antigen binding stability under experimental conditions

  • Application: Design species-specific negative controls based on computational predictions

Recent advances in protein design algorithms, as demonstrated in the development of de novo antibodies with atomic-level precision , provide valuable insights for experimental optimization. These computational approaches can help researchers predict potential experimental pitfalls before they occur, significantly improving experimental efficiency and reliability when working with YJR071W antibody.

What are the most effective approaches for troubleshooting non-specific binding with YJR071W antibody?

Non-specific binding is a common challenge when working with antibodies, including YJR071W antibody. Implementing a structured troubleshooting approach can effectively address this issue:

• Systematic binding optimization matrix:

  Parameter	Standard Condition	Optimization Options
  Blocking Agent	5% BSA	Test 5% milk, commercial blockers, protein-free blockers
  Antibody Dilution	Manufacturer's recommendation	Prepare titration series (1:500 to 1:5000)
  Washing Stringency	TBST (0.1% Tween-20)	Increase detergent (0.3-0.5% Tween-20); add 0.1-0.5% SDS
  Incubation Temperature	Room temperature	Test 4°C overnight; compare to 37°C for 1 hour
  Buffer Salt Concentration	150 mM NaCl	Test higher ionic strength (250-500 mM NaCl)

• Advanced background reduction strategies:

  • Pre-adsorption: Incubate antibody with negative control lysate (e.g., YJR071W knockout yeast) before use

  • Cross-linker quenching: Add 50 mM glycine or 100 mM Tris after fixation to block reactive groups

  • Endogenous enzyme blocking: Use peroxidase quenching solutions before immunodetection

  • Protein A/G pre-clearing: Remove naturally occurring immunoglobulins from complex samples

• Application-specific approaches:

  • For Western blots: Implement gradient transfer conditions; use reversible protein stains to verify transfer

  • For ELISA: Employ sandwich format with capture antibody to increase specificity

  • For immunofluorescence: Test different fixation protocols; use confocal microscopy to reduce out-of-focus signal

• Validation and controls:

  • Perform peptide competition assays to confirm binding specificity

  • Include isotype control antibodies at matching concentrations

  • Implement knockout or knockdown controls in all experiments

YCharOS data has demonstrated that non-specific binding is a widespread issue across commercial antibodies . Their comprehensive analysis suggests that antibodies showing poor selectivity in one application often show similar issues in other applications . Therefore, thorough validation across multiple experimental conditions is essential for obtaining reliable results with YJR071W antibody.

How can new antibody engineering technologies be applied to improve YJR071W antibody specificity?

Recent advances in antibody engineering technologies offer promising approaches to enhance YJR071W antibody specificity:

• Recombinant antibody development:

  • Single-chain variable fragments (scFvs) can be engineered from existing YJR071W polyclonal antibodies

  • Phage display technology can select high-affinity binders with reduced cross-reactivity

  • Yeast surface display systems, including those using autonomous hypermutation, can rapidly generate improved variants

  • Application: Converting polyclonal YJR071W antibodies to recombinant formats with defined specificity profiles

• Affinity maturation strategies:

  • In vitro evolution using OrthoRep or similar systems can improve binding affinity while maintaining specificity

  • Directed evolution approaches can select for antibodies with reduced cross-reactivity to homologous proteins

  • Computational design using fine-tuned RFdiffusion networks can optimize binding interfaces

  • Application: Generating YJR071W antibodies with single-digit nanomolar affinities while preserving epitope selectivity

• Structure-guided engineering:

  • Computational protein design using atomic-level precision can create antibodies with predetermined binding characteristics

  • Cryo-EM structural analysis can inform rational design of improved binding domains

  • CDR (complementarity-determining region) optimization can enhance both affinity and specificity

  • Application: Designing YJR071W antibodies with precisely targeted epitope recognition

• Advanced validation approaches:

  • Implementing YCharOS-style comprehensive characterization across multiple applications

  • Developing synthetic reference standards for absolute quantification

  • Application: Creating next-generation YJR071W antibodies with documented performance characteristics

Recent research has demonstrated that combining computational protein design with yeast display screening can generate antibodies with atomic-level precision in their binding properties . These approaches could potentially transform YJR071W research by providing reagents with unprecedented specificity and reproducibility, addressing the widespread issues of antibody validation identified by initiatives like YCharOS .

What role might YJR071W antibody play in advanced systems biology approaches to studying yeast cellular networks?

YJR071W antibody can serve as a powerful tool in systems biology approaches to unravel complex yeast cellular networks:

• Integrative multi-omics studies:

  • Correlation of protein levels (detected by YJR071W antibody) with transcriptomics data

  • Integration with metabolomics to link YJR071W function to metabolic pathways

  • Combination with phosphoproteomics to map regulatory networks involving YJR071W

  • Application: Creating comprehensive multi-level models of cellular processes involving YJR071W

• Network perturbation analysis:

  • Antibody-based detection of YJR071W in response to genetic or environmental perturbations

  • Quantitative analysis of protein complex dynamics under stress conditions

  • Tracking of YJR071W localization changes in response to cellular signals

  • Application: Mapping the functional position of YJR071W within resilience networks

• Spatial systems biology approaches:

  • Super-resolution microscopy combined with YJR071W antibody detection

  • Multiplexed protein detection to map spatial relationships within cellular compartments

  • In situ proximity ligation to identify context-dependent protein interactions

  • Application: Creating spatiotemporal maps of YJR071W function within cellular microenvironments

• Advanced computational integration:

  • Bayesian network analysis incorporating antibody-based quantification data

  • Machine learning approaches to identify patterns in YJR071W behavior across conditions

  • Agent-based modeling to simulate YJR071W's role in cellular processes

  • Application: Developing predictive models of cellular behavior based on YJR071W dynamics

These systems biology approaches align with modern research practices that emphasize comprehensive validation of research antibodies . As validation initiatives like YCharOS continue to develop standardized approaches for antibody characterization , researchers can increasingly incorporate antibody-based detection into rigorous systems biology workflows with greater confidence in the reliability of their data.

How can I contribute validation data for YJR071W antibody to improve research reproducibility?

Contributing validation data for YJR071W antibody can significantly improve research reproducibility and aligns with emerging best practices in antibody research:

• Comprehensive validation documentation:

  • Perform and document the five pillars of antibody validation as outlined by the International Working Group for Antibody Validation :
    a. Genetic validation using YJR071W knockout yeast strains
    b. Orthogonal validation comparing antibody results with independent methods
    c. Independent antibody validation using multiple antibodies targeting different epitopes
    d. Expression validation across conditions with varying target expression
    e. Immunocapture followed by mass spectrometry validation

  • Create detailed protocols including all experimental parameters and lot numbers

• Data sharing platforms:

  • Contribute to community resources such as:
    a. Antibody Registry (antibodyregistry.org) by registering validation data
    b. YCharOS-style open characterization initiatives
    c. Discipline-specific repositories relevant to yeast biology

  • Include comprehensive methodology documentation and raw data when possible

• Publication strategies:

  • Include detailed validation data in manuscript supplements

  • Consider publishing dedicated antibody validation studies in specialized journals

  • Advocate for inclusion of structured antibody reporting in journal guidelines

  • Implement RRID (Research Resource Identifier) citation for the antibody in publications

• Collaborative validation approaches:

  • Participate in multi-laboratory validation studies

  • Contribute to round-robin testing of antibody performance across sites

  • Share validated protocols through protocol sharing platforms

The YCharOS initiative has demonstrated the value of comprehensive antibody characterization data, particularly using knockout validation approaches . Their model of presenting data through accessible repositories like Zenodo and F1000 provides an excellent template for contributing YJR071W antibody validation data . By rigorously documenting both successful and failed validation attempts, researchers can collectively improve the reliability of YJR071W antibody as a research tool.

What are the most important considerations when selecting and working with YJR071W antibody for yeast research?

When selecting and working with YJR071W antibody for yeast research, several critical considerations should guide your experimental approach: